ProQR Announces that QR-010 Meets the Primary Endpoint in a Proof of Concept Study of Homozygous F508del Cystic Fibrosis Patients Press release … from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. About … Outubro 27, 2016
ProQR Announces Results for the Third Quarter of 2015 and Provides Update on Clinical Trials Press release LEIDEN, The Netherlands, Nov. 23, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. Novembro 23, 2015
ProQR Therapeutics Announces Results for the Third Quarter of 2014 Press release LEIDEN, the Netherlands, Nov. 24, 2014 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. Novembro 24, 2014
ProQR Announces Financial Results for the First Quarter of 2019 Press release … programs towards the clinic in our effort to bring more innovative medicines for inherited retinal diseases to … abstract was presented at the Retinal Cell & Gene Therapy Innovation Summit, three abstracts were presented at the … Maio 08, 2019
ProQR Announces Financial Results for the Second Quarter of 2018 Press release … from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. … Agosto 08, 2018
ProQR Therapeutics Announces Results for the Fourth Quarter and Full Year 2014 Press release LEIDEN, Netherlands, Feb. 26, 2015 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. Fevereiro 26, 2015
ProQR Announces First Quarter 2022 Operating and Financial Results Press release … at the Seventh Annual Retinal Cell and Gene Therapy Innovation Summit, April 29, 2022, and the Association for … Maio 05, 2022
ProQR Reports Fourth Quarter and Full Year 2018 Operating and Financial Results Press release LEIDEN, The Netherlands & CAMBRIDGE, Mass., Feb. 27, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. Fevereiro 27, 2019